Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Scheid

Showing results (1111-1120 of 1,291) with videos related to

Pageof 130
Sort By:
Science Advances|May 27, 2021
Disruption of paternal circadian rhythm affects metabolic health in male offspring via nongerm cell factorsMaximilian Lassi, Archana Tomar, Gemma Comas-Armangué, et al.
Nature Communications|October 23, 2023
DNMT and HDAC inhibition induces immunogenic neoantigens from human endogenous retroviral element-derived transcriptsAshish Goyal, Jens Bauer, Joschka Hey, et al.
Scientific Reports|September 22, 2017
Cerebellar anatomical alterations and attention to eyes in autismCharles Laidi, Jennifer Boisgontier, M Mallar Chakravarty, et al.
Blood Advances|January 19, 2018
Prognostic significance of cytogenetic heterogeneity in patients with newly diagnosed multiple myelomaMaximilian Merz, Anna Jauch, Thomas Hielscher, et al.
The Journal of Experimental Medicine|February 8, 2023
Remodeling of colon plasma cell repertoire within ulcerative colitis patientsJohannes F Scheid, Basak Eraslan, Andrew Hudak, et al.
Bone Marrow Transplantation|October 2, 2019
Analysis of data collected in the European Society for Blood and Marrow Transplantation (EBMT) Registry on a cohort of lymphoma patients receiving plerixaforAnna Sureda, Christian Chabannon, Tamás Masszi, et al.
Blood|July 3, 2010
Allogeneic stem cell transplantation provides durable disease control in poor-risk chronic lymphocytic leukemia: long-term clinical and MRD results of the German CLL Study Group CLL3X trialPeter Dreger, Hartmut Döhner, Matthias Ritgen, et al.
Blood|December 18, 2010
Testing G-CSF responsiveness predicts the individual susceptibility to infection and consecutive treatment in recipients of high-dose chemotherapyChristian Straka, Michael Sandherr, Hans Salwender, et al.
European Journal of Haematology|November 11, 2025
Prognostic Impact of the Hevylite Assay in Patients With IgG or IgA Multiple Myeloma Treated Within the GMMG-MM5 TrialTim Richardson, Elias Mai, Ekaterina Menis, et al.
Plos One|July 27, 2010
Identification of pathway-biased and deleterious melatonin receptor mutants in autism spectrum disorders and in the general populationPauline Chaste, Nathalie Clement, Oriane Mercati, et al.
Pageof 130

Showing results (1111-1120 of 1,291) with videos related to

Sort By:
Pageof 130
Science Advances|May 27, 2021
Disruption of paternal circadian rhythm affects metabolic health in male offspring via nongerm cell factorsMaximilian Lassi, Archana Tomar, Gemma Comas-Armangué, et al.
Nature Communications|October 23, 2023
DNMT and HDAC inhibition induces immunogenic neoantigens from human endogenous retroviral element-derived transcriptsAshish Goyal, Jens Bauer, Joschka Hey, et al.
Scientific Reports|September 22, 2017
Cerebellar anatomical alterations and attention to eyes in autismCharles Laidi, Jennifer Boisgontier, M Mallar Chakravarty, et al.
Blood Advances|January 19, 2018
Prognostic significance of cytogenetic heterogeneity in patients with newly diagnosed multiple myelomaMaximilian Merz, Anna Jauch, Thomas Hielscher, et al.
The Journal of Experimental Medicine|February 8, 2023
Remodeling of colon plasma cell repertoire within ulcerative colitis patientsJohannes F Scheid, Basak Eraslan, Andrew Hudak, et al.
Bone Marrow Transplantation|October 2, 2019
Analysis of data collected in the European Society for Blood and Marrow Transplantation (EBMT) Registry on a cohort of lymphoma patients receiving plerixaforAnna Sureda, Christian Chabannon, Tamás Masszi, et al.
Blood|July 3, 2010
Allogeneic stem cell transplantation provides durable disease control in poor-risk chronic lymphocytic leukemia: long-term clinical and MRD results of the German CLL Study Group CLL3X trialPeter Dreger, Hartmut Döhner, Matthias Ritgen, et al.
Blood|December 18, 2010
Testing G-CSF responsiveness predicts the individual susceptibility to infection and consecutive treatment in recipients of high-dose chemotherapyChristian Straka, Michael Sandherr, Hans Salwender, et al.
European Journal of Haematology|November 11, 2025
Prognostic Impact of the Hevylite Assay in Patients With IgG or IgA Multiple Myeloma Treated Within the GMMG-MM5 TrialTim Richardson, Elias Mai, Ekaterina Menis, et al.
Plos One|July 27, 2010
Identification of pathway-biased and deleterious melatonin receptor mutants in autism spectrum disorders and in the general populationPauline Chaste, Nathalie Clement, Oriane Mercati, et al.
Pageof 130